Lanean...

Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease

Drug resistance in HIV-1 protease, a barrier to effective treatment, is generally caused by mutations in the enzyme that disrupt inhibitor binding but still allow for substrate processing. Structural studies with mutant, inactive enzyme, have provided detailed information regarding how the substrate...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Altman, Michael D., Nalivaika, Ellen A., Prabu-Jeyabalan, Moses, Schiffer, Celia A., Tidor, Bruce
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2802840/
https://ncbi.nlm.nih.gov/pubmed/17729291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prot.21514
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!